SCHEMBL1675348

SCHEMBL1675348

Cc1nc(-c2ccccc2)oc1-c1ccc2ncnc(NCCc3c[nH]cn3)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 2/20 0.43
LMNA P02545 6/20 0.42
CLK4 Q9HAZ1 15/20 0.42
CYP1A2 P05177 9/20 0.41
CYP3A4 P08684 9/20 0.41
CYP2D6 P10635 8/20 0.41
ALDH1A1 P00352 8/20 0.41
HSD17B10 Q99714 6/20 0.41
TSHR P16473 6/20 0.41
USP2 O75604 5/20 0.41
MAPK1 P28482 4/20 0.41
CYP2C19 P33261 8/20 0.41
HIF1A Q16665 5/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALOX15 P16050 2/20 0.41
CYP2C9 P11712 3/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675090 0.78 CLK1 (0.41) DYRK1ALMNACLK4CYP1A2CYP3A4
SCHEMBL1675022 0.78 CLK1 (0.64) DYRK1ALMNACLK4CYP1A2CYP3A4
SCHEMBL1675136 0.77 LMNA (0.61) DYRK1ALMNACLK4CYP1A2CYP3A4
SCHEMBL1675283 0.77 CLK4 (0.56) DYRK1ALMNACLK4CYP1A2CYP3A4
SCHEMBL1675238 0.76 CLK1 (0.58) DYRK1ALMNACLK4CYP1A2CYP3A4
SCHEMBL1675157 0.75 CLK4 (0.62) DYRK1ALMNACLK4CYP1A2CYP3A4
SCHEMBL1675270 0.74 CLK4 (0.60) DYRK1ALMNACLK4CYP1A2CYP3A4
SCHEMBL1675497 0.74 CLK4 (0.45) DYRK1ALMNACLK4CYP1A2CYP3A4
SCHEMBL1675093 0.74 CLK4 (0.61) DYRK1ALMNACLK4CYP1A2CYP3A4
SCHEMBL1675360 0.74 CLK4 (0.57) LMNACLK4CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed